News Articles Tagged: Survivin

Synergistic Cancer Therapy: How Dihydromyricetin Enhances Chemotherapy Efficacy

Discover the synergistic potential of dihydromyricetin (DHM) when combined with chemotherapy. NINGBO INNO PHARMCHEM CO.,LTD. discusses how DHM enhances sensitivity and overcomes resistance, offering a new paradigm for cancer treatment.

Dihydromyricetin in Ovarian Cancer: Targeting Apoptosis and Overcoming Chemoresistance

Ningbo Innopharmchem presents research on dihydromyricetin's role in ovarian cancer, focusing on apoptosis induction, p53 activation, and reversal of chemoresistance through survivin downregulation. Buy DHM for research.